Font Size: a A A
Keyword [biological agents]
Result: 1 - 20 | Page: 1 of 2
1. The Advanced Treatment Of Psoriasis With New Biological Agents
2. Advances Of Biologic Agents In The Treatment Of Psoriasis
3. The Significance Of Serum Inflammatory Markers In Rheumatoid Arthritis Patients With TNF-alpha Antagonist Therapy
4. Clinical Observation Of Combination Systemic Chemotherapy With Chest Tube Drainage And Intrapleural Administration Of Biological Agents In Patients With Malignant Pleural Effusions From Lung Cancer
5. Biological Agents In The Application Of The Digestive System Disease
6. The Evidence-based Study Of Therapeutic Strategy To Treatment Metastatic Colorectal Cancer
7. Advances In Pharmacotherapy Of Pediatric Uveitis
8. Expression Difference And Significance Of TNF-α、IFN-γ、IL-17、IL-6、IL-10 And IP-10 In Juvenile Idiopathic Arthritis Peripheral Blood
9. The Status Of Vitamin D In Juvenile Idiopathic Arthritis (JIA), The Immune Mechanism Of T Cells In Arthritis Mice, And The Effectiveness Of Biological Agents In The Treatment Of JIA
10. Enteral Nutritional Therapy For Induction Of Remission In Crohn's Disease:A Meta-analysis
11. Effects Of Biologics On The Outcome Of Rheumatoid Arthritis Associated Interstitial Lung Disease
12. The Comparison Of Glucocorticoids And Biological Agents On Disease Activity And Bone Mineral Density For Early Active Rheumatoid Arthritis
13. Advances In Immunotherapy Of Inflammatory Bowel Disease
14. A Meta-analysis Of The Efficacy And Safety Of Biologics For The Treatment Of Moderate To Severe Plaque Psoriasis
15. Clinicalanalysis Of Polyarticular Juvenile Idiopathic Arthritis In 156 Cases
16. Clinical Analysis Of Polyarticular Juvenile Idiopathic Arthritis And Mid-long Term Follow-up Observation Of Non-traditional Treatment
17. Study On The Production Technology,quality Standard,stability And Immunity Of Biological Agents TPIN And TPKH
18. The design, synthesis, and biological evaluation of novel antitumor agents
19. Evaluating Awareness and Knowledge of Bioterrorism in Anesthesia Providers
20. Characterizing accidents, exposures, and laboratory-acquired infections reported to the national institutes of health's office of biotechnology activities (NIH/OBA) involving recombinant DNA biological agents
  <<First  <Prev  Next>  Last>>  Jump to